Anti-interleukin 5 for treating severe refractory vernal keratoconjunctivitis in children: Two cases
- PMID: 38753431
- DOI: 10.1111/pai.14139
Anti-interleukin 5 for treating severe refractory vernal keratoconjunctivitis in children: Two cases
References
REFERENCES
-
- Singh N, Diebold Y, Sahu SK, Leonardi A. Epithelial barrier dysfunction in ocular allergy. Allergy. 2022;77:1360‐1372. doi:10.1111/all.15174
-
- Vichyanond P, Pacharn P, Pleyer U, Leonardi A. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes. Pediatr Allergy Immunol off Publ Eur Soc Pediatr Allergy Immunol. 2014;25(4):314‐322.
-
- Mehta JS, Chen WL, Cheng ACK, et al. Diagnosis, management, and treatment of vernal keratoconjunctivitis in Asia: recommendations from the Management of Vernal Keratoconjunctivitis in Asia expert working group. Front Med. 2022;9:882240.
-
- Bonini S, Bonini S, Lambiase A, et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long‐term followup. Ophthalmology. 2000;107(6):1157‐1163.
-
- Leonardi A, Sathe S, Bortolotti M, Beaton A, Sack R. Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients. Allergy. 2009;64(5):710‐717.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources